Back to Search
Start Over
[Medication-related osteonecrosis of the jaws associated with the use of bone-modifying agents].
- Source :
-
Stomatologiia [Stomatologiia (Mosk)] 2024; Vol. 103 (1), pp. 59-62. - Publication Year :
- 2024
-
Abstract
- The relevance of the study is associated with the widespread use of osteomodifying agents in patients with bone metastases and osteoporosis. Bisphosphonates and other osteo-modifying agents are widely used in oncology and prevention of age-related changes in the human bone system. The use, therapeutic effects and complications of therapy with osteo modifying agents are being investigated all over the world. However, the etiology and pathogenesis of drug-induced osteonecrosis of the jaws (MONCH) have not been fully studied, in this regard, the study of risk factors and mechanisms of its development remains relevant. New data on the etiology and pathogenesis of drug-induced osteonecrosis are presented. The literature review is carried out on the electronic resource PubMed.
- Subjects :
- Humans
Diphosphonates adverse effects
Jaw
Bisphosphonate-Associated Osteonecrosis of the Jaw therapy
Bisphosphonate-Associated Osteonecrosis of the Jaw drug therapy
Bone Density Conservation Agents adverse effects
Jaw Diseases chemically induced
Osteonecrosis chemically induced
Osteoporosis
Subjects
Details
- Language :
- Russian
- ISSN :
- 0039-1735
- Volume :
- 103
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Stomatologiia
- Publication Type :
- Academic Journal
- Accession number :
- 38372609
- Full Text :
- https://doi.org/10.17116/stomat202410301159